Business and Finance

Drug makers Merck & Co. and Schering-Plough Corp. will pay $5.4 million to settle a multistate investigation that they delayed the release of test results casting doubt on the effectiveness of two blockbuster cholesterol drugs. The companies settled with attorneys general from 35 states, including Missouri and Illinois, and the District of Columbia online health insurance. The study compared Zetia and Vytorin with Zocor, a drug that is one of Vytorin’s ingredients. (AP)

Source